South Korean AI startup ARK secured $13.7M Series A for chronic disease screening, reaching 700+ cli...
The AMW Read
The article provides an incremental update on a new player in the AI-driven chronic disease screening vertical, but the $13.7M funding round falls below the $500M threshold for a cross.§D capital tag.
NoveltySignificance
Healthcare & Bio · Player Map
South Korean AI startup ARK secured $13.7M Series A for chronic disease screening, reaching 700+ clinics in its first year. This signals accelerating momentum in AI-powered preventive care as chronic disease complications strain healthcare systems globally. With South Korea's $645M medtech R&D push and the $16B deep learning diagnostics market, we're witnessing a systemic shift toward early detection infrastructure. ARK's university hospital-backed AI shows how clinical partnerships enable rapid real-world deployment.